S. Bretagne et al., DETECTION OF TOXOPLASMA-GONDII BY COMPETITIVE DNA AMPLIFICATION OF BRONCHOALVEOLAR LAVAGE SAMPLES, The Journal of infectious diseases, 168(6), 1993, pp. 1585-1588
The prevalence of pulmonary toxoplasmosis was assessed by a prospectiv
e analysis of 144 bronchoalveolar lavage (BAL) samples using competiti
ve polymerase chain reaction (PCR) to avoid false-negative results due
to PCR techniques. Six samples were excluded because they contained a
mplification reaction inhibitors. None of the samples from the 37 immu
nocompetent patients and only 1 sample (1.7%) from the 59 immunocompro
mised patients without human immunodeficiency virus infection were PCR
-positive. In contrast, Toxoplasma gondii DNA was found in 6 (14%) of
42 samples from patients with AIDS. All 6 patients had less-than-or-eq
ual-to 40 CD4 cells/muL and anti-Toxoplasma antibodies, and 5 had othe
r sites of Toxoplasma infection. Six other AIDS patients who had recei
ved treatment for cerebral toxoplasmosis were PCR-negative. Thus, pulm
onary toxoplasmosis is frequent in AIDS patients who have other sites
of Toxoplasma infection and low CD4 lymphocyte counts and who are not
receiving prophylaxis.